Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience

Title: Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience
Authors: Piedra-Delgado, L; Chambergo-Michilot, D; Morante, Z; Fairen, C; Jerves-Coello, F; Luque-Benavides, R; Casas, F; Bustamante, E; Razuri-Bustamante, C; Torres-Roman, JS; Fuentes, H; Gomez, H; Narvaez-Rojas, A; De, La, Cruz-Ku, G; Araujo, J
Publisher Information: Public Library of Science; US
Publication Year: 2024
Subject Terms: Breast Neoplasms; Female; Humans; Neoplasm Recurrence; Local; Neoplasm Staging; Peru; Prognosis; Retrospective Studies; Triple Negative Breast Neoplasms; https://purl.org/pe-repo/ocde/ford#3.02.21
Description: Background Evidence regarding differences in survival associated with the site of metastasis in triplenegative breast cancer (TNBC) remains limited. Our aim was to analyze the overall survival (OS), distant relapse free survival (DRFS), and survival since the diagnosis of the relapse (MS), according to the side of metastasis. Methods This was a retrospective study of TNBC patients with distant metastases at the Instituto Nacional de Enfermedades Neoplasicas (Lima, Peru) from 2000 to 2014. Prognostic factors were determined by multivariate Cox regression analysis. Results In total, 309 patients were included. Regarding the type of metastasis, visceral metastasis accounted for 41% and the lung was the most frequent first site of metastasis (33.3%). With a median follow-up of 10.2 years, the 5-year DRFS and OS were 10% and 26%, respectively. N staging (N2-N3 vs. N0, HR = 1.49, 95%CI: 1.04-2.14), metastasis in visceral sites (vs. bone; HR = 1.55, 95%CI: 0.94-2.56), the central nervous system (vs. bone; HR = 1.88, 95% CI: 1.10-3.22), and multiple sites (vs. bone; HR = 2.55, 95%CI:1.53-4.25) were prognostic factors of OS whereas multiple metastasis (HR = 2.30, 95% CI: 1.42-3.72) was a predictor of MS. In terms of DRFS, there were no differences according to metastasis type or solid organ. Conclusion TNBC patients with multiple metastasis and CNS metastasis have an increased risk of death compared to those with bone metastasis in terms of OS and MS.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https: //doi.org/10.1371/journal.pone.0293833; https://hdl.handle.net/20.500.14703/398; PLoS ONE
DOI: 10.1371/journal.pone.0293833
Availability: https://hdl.handle.net/20.500.14703/398; https://doi.org/10.1371/journal.pone.0293833
Rights: info:eu-repo/semantics/openAccess ; https//creativecomons.org/licenses/by/4.0/
Accession Number: edsbas.2124F1B8
Database: BASE